Jericho Assisted Living
Wednesday, May 25, 2016
Sanofi T2D Combo Injection Wins FDA Panel Support
(MedPage Today) -- Close to unanimous approval of the insulin glargine/lixisenatide combination
via
Sanofi T2D Combo Injection Wins FDA Panel Support
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment